Jennison Associates’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72M | Sell |
715,606
-32,707
| -4% | -$3.29M | 0.04% | 166 |
|
|
2025
Q1 | $57.1M | Sell |
748,313
-25,500
| -3% | -$1.95M | 0.04% | 194 |
|
|
2024
Q4 | $53.4M | Buy |
773,813
+4,560
| +0.6% | +$315K | 0.03% | 219 |
|
|
2024
Q3 | $56.2M | Buy |
769,253
+24,973
| +3% | +$1.82M | 0.03% | 210 |
|
|
2024
Q2 | $49.9M | Buy |
744,280
+625,768
| +528% | +$41.9M | 0.03% | 212 |
|
|
2024
Q1 | $3.22M | Sell |
118,512
-2,319
| -2% | -$62.9K | ﹤0.01% | 447 |
|
|
2023
Q4 | $3.74M | Buy |
+120,831
| New | +$3.74M | ﹤0.01% | 435 |
|
|
2017
Q4 | – | Sell |
-1,506,142
| Closed | -$47M | – | 667 |
|
|
2017
Q3 | $47M | Buy |
1,506,142
+338,877
| +29% | +$10.6M | 0.05% | 282 |
|
|
2017
Q2 | $20M | Sell |
1,167,265
-174
| -0% | -$2.99K | 0.02% | 409 |
|
|
2017
Q1 | $20.4M | Hold |
1,167,439
| – | – | 0.02% | 417 |
|
|
2016
Q4 | $15.4M | Buy |
1,167,439
+3,646
| +0.3% | +$48.2K | 0.02% | 441 |
|
|
2016
Q3 | $16.9M | Sell |
1,163,793
-31,662
| -3% | -$460K | 0.02% | 434 |
|
|
2016
Q2 | $11.8M | Buy |
1,195,455
+17,951
| +2% | +$177K | 0.01% | 450 |
|
|
2016
Q1 | $14.9M | Buy |
1,177,504
+8,744
| +0.7% | +$111K | 0.02% | 429 |
|
|
2015
Q4 | $21.2M | Buy |
1,168,760
+4,159
| +0.4% | +$75.5K | 0.02% | 414 |
|
|
2015
Q3 | $21.6M | Sell |
1,164,601
-7,395
| -0.6% | -$137K | 0.02% | 426 |
|
|
2015
Q2 | $28.6M | Buy |
1,171,996
+8,440
| +0.7% | +$206K | 0.03% | 414 |
|
|
2015
Q1 | $24.2M | Buy |
1,163,556
+400,953
| +53% | +$8.34M | 0.02% | 426 |
|
|
2014
Q4 | $11.8M | Sell |
762,603
-37,835
| -5% | -$585K | 0.01% | 476 |
|
|
2014
Q3 | $10.4M | Buy |
+800,438
| New | +$10.4M | 0.01% | 477 |
|